BALA CYNWYD, Pa., July 16, 2015 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Receptos, Inc. ("Receptos" or "the Company") (Nasdaq -RCPT-News) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Celgene Corporation ("Celgene").
Click here to learn more about the investigation http://brodsky-smith.com/964-rcpt-receptos-inc.html, or call: 877-534-2590. There is no cost or obligation to you.
Under the terms of the transaction, Receptos shareholders will receive only $232.00 in cash for each share of Receptos stock they own. The investigation concerns whether the Board of Receptos breached their fiduciary duties to shareholders and whether Celgene is underpaying for Receptos. The transaction may undervalue the Company given Receptos has a strong pipeline which includes drug candidates for ulcerative colitis, Cohn's disease, relapsing multiple sclerosis, inflammatory bowel disease, and eosinophilic esophagitis. Consequently, an analyst has set a price target for Receptos stock at $348.00 per share.
If you own shares of Receptos and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, by visiting http://brodsky-smith.com/964-rcpt-receptos-inc.html, or calling toll free 877-LEGAL-90.
Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.
SOURCE Brodsky & Smith, LLC